Financials

News Discussions Technicals Seasonals

PUR fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Pure Biologics SA engages in the research and development of biological drug and non-systemic therapies. It focuses on immuno-oncology, autoimmunology, and rare neurological diseases. The company was founded by Filip Jan Jelen, Maciej Piotr Mazurek, Piotr Jan Jakimowicz, Jacek Józef Otlewski, and Andrzej Jan Trznade and in 2010 and is headquartered in Wroclaw, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

PUR has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company